Display options
Share it on

Exp Ther Med. 2017 Dec;14(6):5363-5370. doi: 10.3892/etm.2017.5219. Epub 2017 Sep 29.

Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.

Experimental and therapeutic medicine

Dexin Wang, Ping Zhang, Min Zhang

Affiliations

  1. Department of Medicine, The Sixth People's Hospital of Qingdao, Qingdao, Shandong 266033, P.R. China.

PMID: 29285064 PMCID: PMC5740558 DOI: 10.3892/etm.2017.5219

Abstract

The aim of the present study was to evaluate the predictors for advanced liver fibrosis in patients with chronic hepatitis B virus (HBV) infection with persistently normal alanine aminotransferase (PNALT), or persistently or intermittently mildly elevated ALT (PIEALT). A total of 305 patients were included in the present study. Liver biopsies were evaluated using the METAVIR scoring system. Liver stiffness (LS) was measured using Fibroscan. Multivariate logistic regression and the area under the receiver operating characteristic curve (AUROC) were used to examine the diagnostic value of the predictors for advanced liver fibrosis. HBV DNA viral load in the PNALT group was significantly lower compared with the PIEALT group (4.57±1.68 vs. 5.71±1.69 log

Keywords: Fibroscan; METAVIR scoring system; alanine aminotransferase; hepatitis B; liver fibrosis; upper limit of normal

References

  1. Clin Gastroenterol Hepatol. 2017 Apr;15(4):504-510 - PubMed
  2. Int J Mol Med. 2012 Dec;30(6):1443-50 - PubMed
  3. Clin Exp Med. 2016 Aug;16(3):429-36 - PubMed
  4. Int J Mol Med. 2015 Sep;36(3):747-52 - PubMed
  5. Front Pharmacol. 2017 Feb 09;8:56 - PubMed
  6. Ultrasound Med Biol. 2003 Dec;29(12 ):1705-13 - PubMed
  7. Drug Discov Today. 2016 Feb;21(2):369-75 - PubMed
  8. J Gastroenterol Hepatol. 2011 Aug;26(8):1318-25 - PubMed
  9. Gut. 2005 Nov;54(11):1610-4 - PubMed
  10. Mol Med Rep. 2015 Oct;12(4):5647-54 - PubMed
  11. Hepatology. 1999 Mar;29(3):719-27 - PubMed
  12. Int J Mol Med. 2011 Mar;27(3):385-92 - PubMed
  13. Hepatology. 2016 Jan;63(1):261-83 - PubMed
  14. Medicine (Baltimore). 2017 Jun;96(22):e7021 - PubMed
  15. J Viral Hepat. 1997 May;4(3):199-208 - PubMed
  16. Hepatol Int. 2012 Jun;6(3):531-61 - PubMed
  17. Hepatol Int. 2016 Jan;10 (1):1-98 - PubMed
  18. Therap Adv Gastroenterol. 2017 Feb;10 (2):207-217 - PubMed
  19. Vaccine. 2012 Mar 9;30(12):2212-9 - PubMed
  20. Mymensingh Med J. 2015 Jul;24(3):649-56 - PubMed
  21. J Hepatol. 2012 Aug;57(2):399-420 - PubMed
  22. N Engl J Med. 2001 Feb 15;344(7):495-500 - PubMed
  23. Vaccine. 2006 Mar 15;24(12):1975-82 - PubMed
  24. J Ultrasound Med. 2017 Feb;36(2):261-268 - PubMed
  25. Gut. 2017 Jan;66(1):195-196 - PubMed
  26. Ann Intern Med. 2002 Jul 2;137(1):1-10 - PubMed
  27. Gastroenterology. 2008 May;134(5):1376-84 - PubMed
  28. Can J Gastroenterol Hepatol. 2016;2016:9343960 - PubMed
  29. Discov Med. 2017 Jan;23 (124):19-25 - PubMed
  30. BMC Infect Dis. 2014 Feb 14;14:85 - PubMed
  31. Hepatology. 2009 Jun;49(6):1859-67 - PubMed
  32. J Viral Hepat. 2009 May;16(5):300-14 - PubMed
  33. Scand J Clin Lab Invest. 2016;76(2):133-42 - PubMed
  34. Hepatology. 2007 May;45(5):1193-8 - PubMed
  35. J Hepatol. 2009 Aug;51(2):403-10 - PubMed
  36. Mol Med Rep. 2015 Jul;12(1):1584-90 - PubMed

Publication Types